These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35047533)

  • 1. Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients.
    Hu Z; Huang X; Zhang J; Fu S; Ding D; Tao Z
    Front Med (Lausanne); 2021; 8():792135. PubMed ID: 35047533
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2.
    Zhang J; Chen N; Zhao D; Zhang J; Hu Z; Tao Z
    Front Med (Lausanne); 2022; 9():912367. PubMed ID: 35615088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
    Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
    Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinical characteristics between patients with seasonal influenza and patients infected by the wild type or delta variant of SARS-CoV-2.
    Zhang J; Huang X; Tao Z
    Front Public Health; 2022; 10():981233. PubMed ID: 36062112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant.
    Sawano M; Takeshita K; Ohno H; Oka H
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35580553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Hypertension Comorbidity on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type, the Delta or Omicron Variant SARS-CoV-2.
    Zhang J; Zhang J; Tao Z
    Rev Cardiovasc Med; 2022 Dec; 23(12):395. PubMed ID: 39076657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
    Zhang J; Zhang J; Tao Z
    Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant.
    Fernández-de-Las-Peñas C; Cancela-Cilleruelo I; Rodríguez-Jiménez J; Gómez-Mayordomo V; Pellicer-Valero OJ; Martín-Guerrero JD; Hernández-Barrera V; Arendt-Nielsen L; Torres-Macho J
    Pathogens; 2022 Jun; 11(7):. PubMed ID: 35889971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Red Blood Cell Distribution Width and COVID-19 Severity in Delta Variant SARS-CoV-2 Infection.
    Zhang J; Hu J; Huang X; Fu S; Ding D; Tao Z
    Front Med (Lausanne); 2022; 9():837411. PubMed ID: 35265643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shift in Demographic Involvement and Clinical Characteristics of COVID-19 From Wild-Type SARS-CoV-2 to the Delta Variant in the Indian Population: In Silico Analysis.
    Kumar A; Asghar A; Raza K; Narayan RK; Jha RK; Satyam A; Kumar G; Dwivedi P; Sahni C; Kumari C; Kulandhasamy M; Motwani R; Kaur G; Krishna H; Kumar S; Sesham K; Pandey SN; Parashar R; Kant K
    Interact J Med Res; 2024 Oct; 13():e44492. PubMed ID: 39378428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.
    Chen Y; Bai J
    Arch Gynecol Obstet; 2020 Sep; 302(3):545-551. PubMed ID: 32696241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the protective effect of vaccination and clinical features between the SARS-CoV-2 wild-type strain and Delta (B.1.617.2) variant.
    Li Y; Wang Z; Liu J; Han J; Yang L
    Arch Med Sci; 2022; 18(6):1678-1682. PubMed ID: 36457976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?
    Gunadi ; Hakim MS; Wibawa H; Marcellus ; Setiawaty V; Slamet ; Trisnawati I; Supriyati E; El Khair R; Iskandar K; Afiahayati ; Siswanto ; Irene ; Anggorowati N; Daniwijaya EW; Nugrahaningsih DAA; Puspadewi Y; Puspitarani DA; Tania I; Vujira KA; Ardlyamustaqim MB; Gabriela GC; Eryvinka LS; Nirmala BC; Geometri ET; Darutama AA; Kuswandani AA; Lestari ; Irianingsih SH; Khoiriyah S; Lestari I; Ananda NR; Arguni E; Nuryastuti T; Wibawa T
    Front Med (Lausanne); 2021; 8():780611. PubMed ID: 34957154
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy.
    Loconsole D; Centrone F; Morcavallo C; Campanella S; Accogli M; Sallustio A; Peccarisi D; Stufano A; Lovreglio P; Chironna M
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.